BST1 and ovarian serous adenocarcinoma: When comparing serous ovarian cancer primary tissue cells to those obtained from the patient’s ascites, Ortolan et al. were able to note that nearly all the primary tumor cells expressed CD157, yet only 10% of the cells isolated from ascites expressed CD157.